Skip to main content
Equibles

OCS · Oculis Holding AG

Track OCS — free

Use OCS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OCS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.73 -0.03 (-0.34%) At close · Oct 2
Rebalance outlook locked
Market Cap
$514.74M
Shares
55.53M
Volume · Oct 2 586.3K Avg daily vol (3M) 269.11K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$8.73 Open$8.82 Day$8.53–8.83 52W close$8.73–32.65 Avg vol 30d228K Short int1.6M · 2.8% float · 9.9d Short vol52% Last earningsNov 5, 2026 DataMay 2021–Oct 2026

Up next

Next earnings call
Nov 5, 2026 Scheduled · in 5 wks
Q1 2026 earnings call transcript
call held May 29, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+6.5%
Year over year
Operating margin
-6,811.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-50.0%
Trailing year
Short interest
2.8%
Latest settlement · 9.9 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −57%
below
Price vs 50-day avg −24%
below
RSI (14) 25
oversold
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −28%
trailing
6-month return −68%
trailing
YTD return −56%
this year
Relative strength −80%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $11 › 200d $20 — 200d above 50d
Institutional flow Accumulating
+3% holders QoQ · +21 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.79% of float · ▲ +4.1% MoM · 9.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
65 holders — near 3-yr high, broad support
Squeeze score 61
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 67%
annualized · 1-yr
Max drawdown −73%
past year
ATR 6.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−57% Bearish
Price vs 50-day avg
−24% Bearish
RSI (14)
25 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $11 › 200d $20 — 200d above 50d
Institutional flow Accumulating
+3% holders QoQ · +21 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.79% of float · ▲ +4.1% MoM · 9.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
65 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $9 Now $9 · 0% Range high $33
vs 200-day avg -57% vs 50-day avg -24%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OCS
Oculis Holding AG
this stock
$514.74M -56.3% — — 2.8%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $133.37B +11.3% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.13B -4.8% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
 $79.40B +544.3% +4.3% — 8.2%
CSLLY
Csl Ltd
 $61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
65
% held
42.6%
Net QoQ
+3.2M sh
Top holder
EQT Fund Management S.a r…
Held Float
View
Held by Funds
Fund positions
4
View
Short & Settlement
Short Interest Rising
Shares short
1.6M
Days to cover
9.9d
Change
+61.7K sh
View
Short Volume
Short vol %
52%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
3.8K
Value
$42.9K
As of
Sep 11, 2026
View
Off-Exchange
Off-exchange %
42.6%
Week of
Aug 24, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 30, 2026
This year
14
View
Proposed Sales
Value
$660.0K
Shares
25.0K
Filed
Mar 9, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 5, 2026
Last webcast
Sep 16, 2026
View
Investor Relations
Upcoming events
4
View

Performance

5D 20D 120D MTD YTD
OCS -5.8% -28.3% -67.8% -6.5% -56.3%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -5.6% -27.8% -80.0% -7.5% -69.1%
Key facts CIK 1953530 CUSIP H5870P102 13F (30d) 2 filings 2 filers Visit website Investor relations